Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 321 - 340 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
Reset 

Health Care Is Unaffordable For Half the Country; Consumers & Physicians Agree On Why

HOUSTON, Sept. 19, 2017 /PRNewswire/ -- Consumers and physicians alike blame insurance companies, drug companies and medical device manufacturers for rising health care costs, according to results of a new nationwide survey produced by the Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US

LONDON, Sept. 18, 2017 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  GlaxoSmithKline plc

Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR-B). The dividend is payable on October 16, 2017 to holders of record of... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017

Alere Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the NYSE Conditioned Upon the Completion of its Acquisition by Abbott

WALTHAM, Mass., Sept. 18, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR) ("Alere"), today announced that it has submitted written notice to the New York Stock Exchange (the "NYSE") of its intention to voluntarily delist its Series B Convertible Perpetual Preferred Stock, par value $0.001 per share... Read more ››

By: PR Newswire Association LLC. - 19 Sep 2017
Related companies:  Alere Health, LLC | Alere San Diego, Inc. | Alere Analytics

PMD Healthcare Announces Collaboration with OptiMed Specialty Pharmacy

ALLENTOWN, Pa. and KALAMAZOO, Mich., Sept. 18, 2017 /PRNewswire/ -- PMD Healthcare of Allentown, Penn., and OptiMed Specialty Pharmacy of Kalamazoo, Mich., have announced a business partnership to offer a strategic hub service that expedites and streamlines patient and provider access to PMD... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  PMD Healthcare Inc.

Ossur Hf : Transactions in relation to share buyback program

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017

Sanofi : Disclosure of trading in own shares

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Sanofi S.A.

Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2017
Related companies:  Summit Therapeutics plc | Summit Medical Products, Inc. | Great Summit Co., Ltd. | Summit Biosciences Inc.

Telephus Medical LLC Announces CEO Mark Benedyk, PhD to Serve on Panel "Advances Against Rare and Resistant Pathogens" at Anti-Infectives Rx Invitation-Only Conference

SAN DIEGO, Sept. 18, 2017 /PRNewswire/ -- Telephus Medical LLC (Telephus), a biotechnology company focused on development of novel antibody therapies for antibiotic-resistant staphylococcal infections, today announced that CEO and President Mark Benedyk, PhD will be attending Anti-Infectives... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Telephus Medical LLC

Elsevier Wins Illustrated Book Award and Four First Place Prizes at 2017 BMA Medical Book Awards

LONDON, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Elsevier Inc. | Elsevier Inc. | Elsevier Inc., SciTech Connect

AbbVie Announces Positive Topline Results from Phase 3 Trial Evaluating VENCLEXTA(TM)/VENCLYXTO(TM) (Venetoclax) Tablets in Combination with Rituxan® (rituximab) for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

NORTH CHICAGO, Ill., Sept. 18, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, today announced that the Phase 3 MURANO study of VENCLEXTA(TM)/VENCLYXTO(TM) (Venetoclax) Tablets in combination with Rituxan® (rituximab)... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  AbbVie Inc.

BiondVax Announces Closing of $10 Million Public Offering of American Depositary Shares and Exercise of Over-allotment Option

NESS ZIONA, Israel, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017

Joslin Diabetes Center Signs Agreement with China Horae Capital Management Group Co., Ltd.

BOSTON, Sept. 18, 2017 /PRNewswire-USNewswire/ -- Joslin Diabetes Center, the world's preeminent diabetes care and research center, today announced it has signed an agreement with China Horae Capital Management Group Co., Ltd. to advise the Horae Nanjing Diabetes Center project currently in development... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Joslin Diabetes Center & Joslin Clinic

Sixteen Emergency Nurses to Join Academy of Emergency Nursing

DES PLAINES, Ill., Sept. 18, 2017 /PRNewswire-USNewswire/ -- The Emergency Nurses Association today announced 16 emergency nurses will be inducted as Fellows into the Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01

CAMBRIDGE, Mass., Sept. 18, 2017 /PRNewswire/ -- Thrombolytic Science, LLC (TSI), a clinical stage vascular health and biotechnology company, today announced the completion of a Phase 1 clinical trial of TS01, a new-generation... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Thrombolytic Science, LLC

Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2017-2023

DUBLIN, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Zyga Announces Highmark, Inc., 4th Largest Blue Cross Blue Shield Insurer, to Expand Positive Coverage of Minimally Invasive SI Joint Fusion

MINNETONKA, Minn., Sept. 18, 2017 /PRNewswire/ -- Zyga Technology, Inc., a medical device company focused on the design, development, and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced that Highmark, Inc., the nation's 4(th)... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Zyga Technology, Inc. | Highmark Companies

Global Biocides and Disinfectants Market 2017-2021 with Akzo Nobel, BASF, Clariant, Kemira & The Dow Chemical Company Dominating

DUBLIN, September 18, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Hyundai Hope On Wheels Awards $250,000 Research Grant To Children's Hospital Of Pittsburgh In Honor Of National Childhood Cancer Awareness Month

PITTSBURGH, Sept. 18, 2017 /PRNewswire/ -- On Wednesday, September 20, 2017, Hyundai Hope On Wheels® will present Children's Hospital of Pittsburgh of UPMC with a $250,000 Hyundai Scholar Hope Grant. The grant funds... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017

Hyundai Hope On Wheels To Award $400,000 Research Grant To Dana-Farber Cancer Institute Of Boston In Honor Of National Childhood Cancer Awareness Month

BOSTON, Sept. 18, 2017 /PRNewswire/ -- On Sunday, September 24, 2017, Hyundai Hope On Wheels® will present Dana-Farber Cancer Institute with a total of $400,000 from the Hyundai Scholar Hope and Young Investigator... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2017
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »
to the top ↑